152 related articles for article (PubMed ID: 36925105)
21. Formation of N-nitrosamines during the analysis of municipal secondary biological nutrient removal process effluents by US EPA method 521.
Chuang YH; Shabani F; Munoz J; Aflaki R; Hammond SD; Mitch WA
Chemosphere; 2019 Apr; 221():597-605. PubMed ID: 30665089
[TBL] [Abstract][Full Text] [Related]
22. A Nitrite Excipient Database: A Useful Tool to Support N-Nitrosamine Risk Assessments for Drug Products.
Boetzel R; Schlingemann J; Hickert S; Korn C; Kocks G; Luck B; Blom G; Harrison M; François M; Allain L; Wu Y; Bousraf Y
J Pharm Sci; 2023 Jun; 112(6):1615-1624. PubMed ID: 35500671
[TBL] [Abstract][Full Text] [Related]
23. Investigating the root cause of N-nitrosodimethylamine formation in metformin pharmaceutical products.
Nasr NEH; Metwaly MG; Ahmed EO; Fares AR; ElMeshad AN
Expert Opin Drug Saf; 2021 Jul; 20(7):855-862. PubMed ID: 33849366
[TBL] [Abstract][Full Text] [Related]
24. Concurrent generation of methylamine and nitrite during denitrosation of N-nitrosodimethylamine by rat liver microsomes.
Keefer LK; Anjo T; Wade D; Wang T; Yang CS
Cancer Res; 1987 Jan; 47(2):447-52. PubMed ID: 3791233
[TBL] [Abstract][Full Text] [Related]
25. Patient In-Use Stability Testing of FDA-Approved Metformin Combination Products for N-Nitrosamine Impurity.
Dharani S; Mohamed EM; Rahman Z; Khan MA
AAPS PharmSciTech; 2024 Jan; 25(1):19. PubMed ID: 38267707
[TBL] [Abstract][Full Text] [Related]
26. Prediction of N-nitrosodimethylamine (NDMA) formation as a disinfection by-product.
Kim J; Clevenger TE
J Hazard Mater; 2007 Jun; 145(1-2):270-6. PubMed ID: 17182179
[TBL] [Abstract][Full Text] [Related]
27. N-nitrosodimethylamine formation during treatment with strong oxidants of dimethylamine containing water.
Andrzejewski P; Nawrocki J
Water Sci Technol; 2007; 56(12):125-31. PubMed ID: 18075188
[TBL] [Abstract][Full Text] [Related]
28. Oral intake of ranitidine increases urinary excretion of N-nitrosodimethylamine.
Zeng T; Mitch WA
Carcinogenesis; 2016 Jun; 37(6):625-634. PubMed ID: 26992900
[TBL] [Abstract][Full Text] [Related]
29. In vivo stability of nitrite and nitrosamine formation in the dog stomach: effect of nitrite and amine concentration and of ascorbic acid.
Lintas CL; Clark A; Fox J; Tannenbaum SR; Newberne PM
Carcinogenesis; 1982; 3(2):161-5. PubMed ID: 7067044
[TBL] [Abstract][Full Text] [Related]
30. N-nitrosodimethylamine formation by free-chlorine-enhanced nitrosation of dimethylamine.
Choi J; Valentine RL
Environ Sci Technol; 2003 Nov; 37(21):4871-6. PubMed ID: 14620812
[TBL] [Abstract][Full Text] [Related]
31. [Risk of endogenous N-nitrosodimethylamine formed by dimethylamine in rats--precursors stability].
Zhu ST; Liu ZC
Zhonghua Yu Fang Yi Xue Za Zhi; 1990 Mar; 24(2):83-5. PubMed ID: 2364803
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the protective effect of ascorbic acid on nitrite- and nitrosamine-induced cytotoxicity and genotoxicity in human hepatoma line.
Erkekoglu P; Baydar T
Toxicol Mech Methods; 2010 Feb; 20(2):45-52. PubMed ID: 20100056
[TBL] [Abstract][Full Text] [Related]
33. In Silico Prediction of N-Nitrosamine Formation Pathways of Pharmaceutical Products.
Tsuji G; Kurohara T; Shoda T; Yokoo H; Ito T; Masada S; Uchiyama N; Yamamoto E; Demizu Y
Chem Pharm Bull (Tokyo); 2024; 72(2):166-172. PubMed ID: 38296559
[TBL] [Abstract][Full Text] [Related]
34. The competitive effect of different chlorination disinfection methods and additional inorganic nitrogen on nitrosamine formation from aromatic and heterocyclic amine-containing pharmaceuticals.
Chen WH; Wang YH; Hsu TH
Chemosphere; 2021 Mar; 267():128922. PubMed ID: 33190909
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous determination of low molecular weight nitrosamines in pharmaceutical products by fast gas chromatography mass spectrometry.
Kalauz A; Tiringer KV; Horváth V; Kapui I
J Chromatogr A; 2023 Oct; 1708():464323. PubMed ID: 37696123
[TBL] [Abstract][Full Text] [Related]
36. Chloramination of nitrogenous contaminants (pharmaceuticals and pesticides): NDMA and halogenated DBPs formation.
Le Roux J; Gallard H; Croué JP
Water Res; 2011 May; 45(10):3164-74. PubMed ID: 21496861
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of nitrosamine contaminants in drug samples: Has the crisis been overcome?
Schmidtsdorff S; Neumann J; Schmidt AH; Parr MK
Arch Pharm (Weinheim); 2023 Feb; 356(2):e2200484. PubMed ID: 36461687
[TBL] [Abstract][Full Text] [Related]
38. Formation of volatile nitrosamines by drug-nitrite interactions under physiological conditions.
Sakai A; Inoue T; Tanimura A
Gan; 1984 Mar; 75(3):245-52. PubMed ID: 6724228
[TBL] [Abstract][Full Text] [Related]
39. Experimental and Theoretical Investigation of Effects of Ethanol and Acetic Acid on Carcinogenic NDMA Formation in Simulated Gastric Fluid.
Zhang O; Zou X; Li QH; Sun Z; Liu YD; Zhong RG
J Phys Chem A; 2016 Jul; 120(26):4505-13. PubMed ID: 27300636
[TBL] [Abstract][Full Text] [Related]
40. N-nitrosodimethylamine (NDMA) formation during ozonation of dimethylamine-containing waters.
Andrzejewski P; Kasprzyk-Hordern B; Nawrocki J
Water Res; 2008 Feb; 42(4-5):863-70. PubMed ID: 17904190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
